U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07016802) titled 'A Clinical Study of GenSci134 in Healthy Male Adults' on May 30.
Brief Summary: To check how safe and well-tolerated a single subcutaneous injection of GenSc134 is in healthy male volunteers
Study Start Date: June 09
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: GenSci134
only one dose of GenSci134 and GenSci134 Placebo to be given, subcutaneous , 7 dose levels will be assigned.
DRUG: GenSci134 Placebo
only one dose of GenSci134 and GenSci134 Placebo to be given, subcutaneous , 7 dose levels will be assigned.
DRUG: Recombinant Human Growth Hormone Injection (Norditropin(R))
A single dose of ...